Aurora Cannabis Inc (ACB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Based on the latest financial reports, Aurora Cannabis Inc (ACB) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($17.00 Million) by net assets ($567.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aurora Cannabis Inc - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Aurora Cannabis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Aurora Cannabis Inc carry for a breakdown of total debt and financial obligations.

Aurora Cannabis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Cannabis Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Atomera Inc
NASDAQ:ATOM
-0.175x
i-SENS Inc
KQ:099190
0.018x
Catella AB (publ)
ST:CAT-B
0.009x
United Pharm
KO:033270
0.051x
Samara Asset Group
F:SRAG
N/A
Mechema Chemicals Int
TWO:4721
0.108x
CVC Brasil Operadora e Agencia
SA:CVCB3
0.347x
Latécoère S.A.
PA:LAT
-0.004x

Annual Cash Flow Conversion Efficiency for Aurora Cannabis Inc (2007–2025)

The table below shows the annual cash flow conversion efficiency of Aurora Cannabis Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Aurora Cannabis Inc market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $605.09 Million $16.00 Million 0.026x +123.28%
2024-03-31 $602.92 Million $-68.51 Million -0.114x +48.81%
2023-03-31 $521.74 Million $-115.82 Million -0.222x -5.04%
2022-03-31 $521.74 Million $-110.27 Million -0.211x -104.26%
2021-03-31 $2.04 Billion $-210.58 Million -0.103x +36.06%
2020-03-31 $2.11 Billion $-342.14 Million -0.162x -270.73%
2019-03-31 $4.40 Billion $-192.25 Million -0.044x +16.43%
2018-03-31 $1.56 Billion $-81.67 Million -0.052x +14.22%
2017-03-31 $219.71 Million $-13.38 Million -0.061x +94.84%
2016-03-31 $5.74 Million $-6.77 Million -1.180x -36.07%
2015-03-31 $3.83 Million $-3.32 Million -0.867x -22.12%
2014-03-31 $1.36 Million $-965.11K -0.710x -9.48%
2013-03-31 $690.35K $-447.84K -0.649x -152.05%
2012-03-31 $1.08 Million $-277.98K -0.257x -28.38%
2011-03-31 $1.37 Million $-275.48K -0.200x -11027.01%
2010-03-31 $1.71 Million $-3.08K -0.002x +92.54%
2009-03-31 $1.62 Million $-39.04K -0.024x +53.41%
2008-03-31 $1.68 Million $-87.26K -0.052x -677.32%
2007-03-31 $1.68 Million $15.11K 0.009x --

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$197.35 Million
Market Cap Rank
#16580 Global
#3750 in USA
Share Price
$3.48
Change (1 day)
+1.16%
52-Week Range
$3.08 - $6.23
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more